Achilles Therapeutics plc (ACHL) Misses Q3 EPS by 7c

Achilles Therapeutics plc (NASDAQ: ACHL) reported Q3 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Achilles Therapeutics plc (ACHL) click here.

You May Also Be Interested In

• Copart (CPRT) call put ratio 1.8 calls 1 put a share price up 3.9%
• John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
• BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18